PartnershipUpdated on 12 August 2025
Biomedical Production Technology (NXTGEN Hightech)
About
Biomedical Production Technology, one of NXTGEN Hightech’s six focus areas, connects cutting-edge science and industry to deliver faster, safer, and more personalized medical technologies. We translate advances in Lab-on-Chip, Organ-on-Chip, Artificial Organs, and Cell Production Technology into scalable, market-ready systems.
Our network of 60+ public and private partners spans high-tech, microtechnology, biology, clinical practice, and regulatory sectors. Together, we bridge the gap between fundamental research and industrial-scale manufacturing, emphasizing regulatory alignment and system standardization to speed up clinical adoption.
We are developing a joint platform that accelerates biomedical technology by offering shared production infrastructure, generic equipment, standardized and qualified processes, and facilities — all accessible via one central virtual hub.
We welcome collaborations with developers, suppliers, researchers, and end-users seeking to innovate in biomedical technology production.
Organisation
Similar opportunities
Service
- Consulting
- Development
- Manufacturing
- Innovative therapies - Microbiome therapy
- High Tech Systems & Materials - Chip design
- Innovative human-based test models - 3D spheroids
- Innovative human-based test models - Organ-on-Chip
- Development stages and support fuctions - Contract research (CRO / CRMO)
- Innovative human-based test models - 2D & 3D in vitro cell culture models
- Development stages and support fuctions - Early discovery / basic research
- Development stages and support fuctions - Technology development and validation
- Development stages and support fuctions - Pre-clinical research and development
Sanne de Wit
Operations and Programme Manager at University of Twente at University of Twente
Enschede, Netherlands
Service
Medical Devices & IVDs & Combination Products Services
- Others
- Consulting
- Development stages and support fuctions - Regulatory and compliance
- Development stages and support fuctions - Technology development and validation
Jane Müller
Head Legal, Business Development representative at Luminance Health
Basel, Switzerland
Service
- Consulting
- Development
- Innovative therapies - Gene therapy
- Innovative therapies - Stem cell therapy
- Innovative therapies - Oncolytic viruses
- Innovative therapies - Immune cell therapy
- Innovative therapies - Somatic cell therapy
- Development stages and support fuctions - Data management and analytics
- Development stages and support fuctions - Contract research (CRO / CRMO)
- Development stages and support fuctions - Clinical research and development
- Development stages and support fuctions - Development and (GMP) manufacturing
- Development stages and support fuctions - Pre-clinical research and development
- Development stages and support fuctions - Commercial strategy and market access
daniel lüscher
CEO at QBDC GmbH
Nusshof, Switzerland